IRCT201402085280N15已完成未知
Effect of Topiramate on body weight of patients with schizophrenia treated with Olanzapine in Ibn-e- Sina Hospital in 2006.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •The inclusion criteria included: Schizophrenia according to DSM-IV-IR; aged between 18-60 years.
- •Exclusion criteria included: Substance abuse in the past six months, a history of seizures, concomitant use of other drugs except benzodiazepines and beta-blockers .
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Topiramate’s effectiveness on weight reduction in overweight/obese persons with SchizophreniaSchizophrenia, Obesity, OverweightSLCTR/2017/003Department of Psychiatry
已完成
3 期
The effect of Topiramate on weight loss in Iranian patients with diabetes type 2Obesity.Obesity, unspecifiedIRCT201112036027N2Tehran University of Medical sciences80
已完成
3 期
Topiramate’s effectiveness on weight reduction and metabolic syndrome in obese patients with schizophrenia and schizoaffectiveIRCT20210622051665N1niversity of social welfare and rehabilitation sciences70
撤回
早期 1 期
Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint ArthroplastyWeight LossPain, PostoperativeNCT04613024Stanford University
已完成
不适用
Weight gain and appetite changes following treatment for thyrotoxicosis – a pilot studyThyrotoxicosisACTRN12616000843459Waikato Hospital20